00:00Novo Nordisk has terminated its partnership with HIMS & HERS, citing concerns over the
00:04telehealth company's promotion and sale of unauthorized compounded versions of popular
00:09weight loss drug WeGoV.
00:12The drug maker accused HIMS & HERS of violating laws prohibiting mass sales of compounded
00:16drugs and using deceptive marketing practices that could endanger patient safety.
00:22Following the announcement, HIMS & HERS stock dropped about 20% in pre-market trading.
Comments